Form 8-K - Current report:
SEC Accession No. 0001396814-21-000040
Filing Date
2021-06-17
Accepted
2021-06-17 16:30:54
Documents
12
Period of Report
2021-06-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20210616.htm   iXBRL 8-K 30198
  Complete submission text file 0001396814-21-000040.txt   166453

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20210616.xsd EX-101.SCH 1921
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20210616_lab.xml EX-101.LAB 24270
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20210616_pre.xml EX-101.PRE 12654
5 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20210616_htm.xml XML 11027
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 211025142
SIC: 2834 Pharmaceutical Preparations